Multiple Sclerosis Foundation - News & Features

Get Educated
What is MS?

A chronic neurological disorder that affects the central nervous system, comprised of the brain...
More Details
Donate
Get Help
Health & Wellness Program

Get educational materials and referrals, as well as the opportunity to participate in various...
Learn More
Get Involved
MS Awareness Month

An annual, nationwide campaign with goals to promote an understanding of MS, and to assist those...
Learn More
Events
Test Flyout

lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem...
Learn More
About Us
Programs & Grants

More Details

Managing Your Pain and... Join us at 7 p.m. Eastern, 6 p.m. Central, 5 p.m. Mountain, 4 p.m. Pacific, on Sept. 27, for the presentation... /Events/MSF-Events/2021/September/Managing-Your-Pain-and-Discomfort

Cooling Program The Cooling Program offers a variety of items, free of charge, to help individuals with MS... /Get-Help/MSF-Programs-Grants/Cooling-Program

MS Focus Lending Library

Books, DVDs, and CDs are available for loan, by...

Books, DVDs, and CDs are available for loan, by mail across the United States.

Get more details Get more details

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life!

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

New research suggests MS patients have robust T-cell responses to mRNA COVID-19 vaccines

September 20, 2021

The study measured both the antibody and T-cell responses in 20 patients with MS who were undergoing anti-CD20 treatment.

Study: MS may affect survival rate after colorectal cancer diagnosis

September 17, 2021

The study found that people with MS were 45 percent more likely to die of any cause at six months after the cancer diagnosis than people without MS.

NIH scientists build a cellular blueprint of MS lesions

September 14, 2021

According to the study’s authors, it’s possible that targeting C1q in human microglia could halt MS lesions in their tracks.

Brain molecule helps cells that could spark remyelination

September 13, 2021

Researchers said the immunological nature of fractalkine could also be important for future drug development.

Researchers examine extreme heat, multiple sclerosis link

August 09, 2021

The findings could guide region-specific strategies to manage MS, such as providing heat advisories and critical information on sudden changes in local weather to MS patients and healthcare providers.

Study finds Wahls and Swank diets both reduce fatigue

August 06, 2021

Findings suggests the benefits of the dietary approaches are due to underlying mechanisms rather than unique characteristics of specific diets.

Study: Disease comparisons offer clues to MS progression

July 21, 2021

New research shows the brain and spinal cord scars in people with multiple sclerosis may offer clues to why they develop progressive disability.

Plant-based diet and a healthy microbiome may protect against MS

July 15, 2021

The study showed a diet rich in isoflavone protects against MS-like symptoms in a mouse model of the disease.

Study suggests high-efficacy treatments reduce relapses in secondary progressive MS

July 09, 2021

A new study found that the more potent disease-modifying drugs are more effective in reducing flare-ups in secondary progressive MS than the less potent drugs that tend to be safer to take.

New research suggests MS patients have robust T-cell responses to mRNA COVID-19 vaccines

September 20, 2021

The study measured both the antibody and T-cell responses in 20 patients with MS who were undergoing anti-CD20 treatment.

Study: MS may affect survival rate after colorectal cancer diagnosis

September 17, 2021

The study found that people with MS were 45 percent more likely to die of any cause at six months after the cancer diagnosis than people without MS.

NIH scientists build a cellular blueprint of MS lesions

September 14, 2021

According to the study’s authors, it’s possible that targeting C1q in human microglia could halt MS lesions in their tracks.

Brain molecule helps cells that could spark remyelination

September 13, 2021

Researchers said the immunological nature of fractalkine could also be important for future drug development.

Researchers examine extreme heat, multiple sclerosis link

August 09, 2021

The findings could guide region-specific strategies to manage MS, such as providing heat advisories and critical information on sudden changes in local weather to MS patients and healthcare providers.

Study finds Wahls and Swank diets both reduce fatigue

August 06, 2021

Findings suggests the benefits of the dietary approaches are due to underlying mechanisms rather than unique characteristics of specific diets.

Study: Disease comparisons offer clues to MS progression

July 21, 2021

New research shows the brain and spinal cord scars in people with multiple sclerosis may offer clues to why they develop progressive disability.

Plant-based diet and a healthy microbiome may protect against MS

July 15, 2021

The study showed a diet rich in isoflavone protects against MS-like symptoms in a mouse model of the disease.

Study suggests high-efficacy treatments reduce relapses in secondary progressive MS

July 09, 2021

A new study found that the more potent disease-modifying drugs are more effective in reducing flare-ups in secondary progressive MS than the less potent drugs that tend to be safer to take.

Study suggests in many cases MS starts long before the diagnosis

June 28, 2021

Researchers found MS patients are often diagnosed years after their first demyelinating event.

iConquerMS seeking participants for COVID-19 study

May 17, 2021

iConquerMS is conducting a study to answer questions on vaccine side effects, possible effects on MS symptoms, and how MS medications might influence vaccine.

Study: Low levels of a simple sugar may be a MS biomarker

May 14, 2021

This opens up potential new avenues for identifying, at an early stage, which patients are at higher risk of progressive MS and adjusting their treatment accordingly.

Social cognition plays a key role in everyday lives of people with MS

May 05, 2021

The study shows people with relapsing-remitting MS performed significantly lower in several social cognition areas, despite being classified as "cognitively normal."

Verbal fluency deficits in MS may reflect impaired language ability

April 30, 2021

The findings suggest the need for more comprehensive neuropsychological testing among people with MS.

Pandemic led to profound changes in MS clinical practice

April 29, 2021

Survey respondents also commented on their perceived level of safety and support in the workplace during the pandemic.

Survey: Coping strategies key to neutral, positive psychological effects from COVID-19

April 28, 2021

Both emotion-focused and problem-focused coping strategies were instrumental in those reporting a neutral or positive effect from the COVID-19 pandemic.

Online exercise programs now available

April 27, 2021

MS Focus is now sponsoring virtual exercise programs for people with multiple sclerosis. The programs are in cooperation with the Working in Wellness Foundation and Sacred Rivers Yoga. The programs are free and ongoing from now until September.

Study: Black people may respond differently to common MS therapy than white people

April 20, 2021

A preliminary study suggests Black people who have multiple sclerosis and neuromyelitis optica spectrum disorder, may respond differently than white people to a common therapy meant to modulate the immune system.

Show More News